Business Description
Taisho Pharmaceutical Holdings Co Ltd
NAICS : 325412
SIC : 2834
ISIN : US87402P1057
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.83 | |||||
Interest Coverage | 87.07 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.59 | |||||
Beneish M-Score | -2.6 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -9.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.74 | |||||
14-Day RSI | 97.27 | |||||
6-1 Month Momentum % | -18.75 | |||||
12-1 Month Momentum % | 28.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.16 | |||||
Quick Ratio | 4.37 | |||||
Cash Ratio | 3.3 | |||||
Days Inventory | 152.71 | |||||
Days Sales Outstanding | 75.47 | |||||
Days Payable | 43.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.61 | |||||
3-Year Dividend Growth Rate | -10.1 | |||||
Forward Dividend Yield % | 1.23 | |||||
5-Year Yield-on-Cost % | 0.61 | |||||
Shareholder Yield % | 1.17 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.17 | |||||
Operating Margin % | 5.8 | |||||
Net Margin % | 2.54 | |||||
FCF Margin % | -3.11 | |||||
ROE % | 1 | |||||
ROA % | 0.83 | |||||
ROIC % | 1.75 | |||||
3-Year ROIIC % | 2.29 | |||||
ROC (Joel Greenblatt) % | 8.25 | |||||
ROCE % | 1.88 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -13.76 | |||||
EV-to-Forward-EBIT | 11.53 | |||||
EV-to-EBITDA | -13.76 | |||||
EV-to-Forward-EBITDA | 4.4 | |||||
EV-to-Revenue | -0.73 | |||||
EV-to-Forward-Revenue | 0.67 | |||||
EV-to-FCF | 23.42 | |||||
Price-to-Median-PS-Value | 18.67 | |||||
Earnings Yield (Greenblatt) % | -7.27 | |||||
FCF Yield % | -30.54 | |||||
Forward Rate of Return (Yacktman) % | -6.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TAIPY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Taisho Pharmaceutical Holdings Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,260.176 | ||
EPS (TTM) ($) | 4757535.48 | ||
Beta | 0 | ||
Volatility % | 53.05 | ||
14-Day RSI | 97.27 | ||
14-Day ATR ($) | 0.11143 | ||
20-Day SMA ($) | 12.5 | ||
12-1 Month Momentum % | 28.21 | ||
52-Week Range ($) | 8.88 - 15.5199 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Taisho Pharmaceutical Holdings Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Taisho Pharmaceutical Holdings Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Taisho Pharmaceutical Holdings Co Ltd Frequently Asked Questions
What is Taisho Pharmaceutical Holdings Co Ltd(TAIPY)'s stock price today?
When is next earnings date of Taisho Pharmaceutical Holdings Co Ltd(TAIPY)?
Does Taisho Pharmaceutical Holdings Co Ltd(TAIPY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |